Form 4: Precision BioSciences Executive Dario Scimeca Reports Stock Transactions
SEC Form 4 Filing
Dario Scimeca, General Counsel and Secretary of Precision BioSciences, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On June 7, 2024, Dario Scimeca vested 301 Restricted Stock Units (RSUs) which converted into common stock.
- Following the vesting, Scimeca sold 93 shares of common stock on June 10, 2024, at an average price of $11.79 per share to cover tax withholding obligations.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2023.
- After these transactions, Scimeca beneficially owns 6,721 shares of Precision BioSciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing represents routine transactions related to executive compensation and tax obligations. The transactions were pre-planned and do not necessarily indicate a change in the executive's confidence in the company.
Positives
- The transactions were part of a pre-planned Rule 10b5-1 trading plan, indicating an orderly and pre-determined approach to stock sales.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company executives and directors.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/14/2023 | Date of adoption of Rule 10b5-1 plan |
| 06/07/2021 | Date the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
| 06/07/2024 | Date of RSU vesting and settlement |
| 06/10/2024 | Date of common stock sale |
| 06/11/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.